Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

TB402 – Treatment of VTE and AF

Drug (Brand/Generic)

TB-402

Company/Licensee

ThromboGenics/BioInvent International

Therapy Class

Anticoagulant

Product Description

Partial inhibitor of coagulation Factor VIII

Current Indication

Primary prevention and treatment of VTE following orthopaedic surgery

Market Sector

Cardiovascular

Development Status

Phase II
Expand

Go Top